Roche

Roche flops Phase III B-cell lymphoma test in head-to-head study

Roche to ax 350 IT jobs in U.S and Europe in shift toward offshoring

Roche’s new multiple sclerosis drug set for early FDA approval

Incyte shrugs off trial failures with Merck PD-1/epacadostat tie-up

Roche-backed researchers find a way to lure back immune system from cancer’s grasp

EuroBiotech Report: Roche extends Oryzon epigenetic alliance

Roche bags a quick approval for PD-L1 blockbuster contender atezo

Roche extends Oryzon epigenetic cancer, hematology R&D collaboration

Kite Pharma’s CAR-T drug begins LA hospital trial in children